We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed... Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California. Show more
Preclinical results of EL-22 from a 2022 study demonstrated physiological (serum creatine kinase level), physical (body weight change), and functional (rotarod test) improvements in the dystrophic...
Elevai Labs established two subsidiaries: Elevai Biosciences, Inc., and Elevai Skincare, Inc.Elevai Biosciences will focus on acquiring and developing biopharmaceutical technologies with initial...
Agreement adds two drug candidates to product pipeline consisting of (i) “EL-22”, a clinical stage engineered probiotic expressing myostatin, and (ii) “EL-32”, a preclinical engineered probiotic...
Five international distribution agreements signed to dateCumulative contracted minimum purchase requirements of $4.9M in the first five yearsUp to five additional international distribution...
Taiwan is ELEVAI’s third Asian contract for exosomes distribution after adding the Philippines in August of 2023 and Vietnam in May 2023 Asia-Pacific represents a combined $13 Billion prestige...
Company reports record annual revenues of $1.71 Million for 2023, up 123.5% over the previous year Company reports record Q4 2023 revenues of $698,591, up 403% from Q4 2022 NEWPORT BEACH, Calif...
ELEVAI Physician-Dispensed Skincare Now Available Direct to Consumers NEWPORT BEACH, CA -- March 18, 2024 -- InvestorsHub NewsWire -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic...
NEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0001 | 0.0147080453008 | 0.6799 | 0.76 | 0.622 | 1016085 | 0.67603987 | CS |
4 | 0.0024 | 0.354191263282 | 0.6776 | 0.76 | 0.5709 | 301356 | 0.66843609 | CS |
12 | 0.008 | 1.19047619048 | 0.672 | 0.88 | 0.5709 | 385083 | 0.7010911 | CS |
26 | -3.32 | -83 | 4 | 4.2442 | 0.5709 | 946474 | 1.17933771 | CS |
52 | -3.32 | -83 | 4 | 4.2442 | 0.5709 | 946474 | 1.17933771 | CS |
156 | -3.32 | -83 | 4 | 4.2442 | 0.5709 | 946474 | 1.17933771 | CS |
260 | -3.32 | -83 | 4 | 4.2442 | 0.5709 | 946474 | 1.17933771 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions